-
Molecular subtyping-guided precision therapy for ESCC: biomarker-driven strategies and clinical translation pathway
Author: Lv, Huifang; Zhao, Wanying; Wang, Sai-Qi; Chen, Xiao-Bing
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04332-6
-
Multidisciplinary consensus recommendations for the management of IDH-mutant grade 2 gliomas in Spain: a Delphi stud
Author: Esparragosa Vazquez, Ines; Fortes De La Torre, Inmaculada; Hilario, Amaya; Iglesias Lozano, Irene; Hernandez-Lain, Aurelio; Pineda, Estela; Sepulveda Sanchez, Juan Manuel; Vaz-Salgado, Maria Angeles
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04338-0
-
First-line versus second-line use of selpercatinib in treatment of RET fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysi
Author: Wang, Kai; Liu, Wenjie
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04318-4
-
Integrative bioinformatic and experimental analysis reveals prognostic and immunological roles of psychological stress-related genes in skin cutaneous melanom
Author: Zheng, Bin; Ge, Yanglu
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04333-5
-
Progress in management of advanced clear-cell renal cell carcinom
Author: Zhang, Letong; Wang, Jingwen; Hu, Junming; Yao, Jiaxi
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04329-1
-
Image-based PD-L1 scoring and tumor-infiltrating lymphocytes as predictors for the response to neoadjuvant chemoimmunotherapy in non-small cell lung cance
Author: Wu, Jianghua; Sun, Wei; Liu, Xinying; Yang, Xin; Mao, Luning; Wang, Chenglong; Diao, Xinting; Lin, Dongmei
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04268-x
-
PET-CT radiomics and artificial intelligence for predicting lymph node metastasis in cervical cancer: a systematic review and meta-analysi
Author: Liu, Xiaoyu; Lei, Junqiang
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04346-0
-
Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic revie
Author: Xu, JiaJu; Ni, ChunXiao; Qin, Lidong; Wang, Ping; Xu, JiaJu
Journal: CLINICAL & TRANSLATIONAL ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s12094-026-04330-8
